home / stock / prvl / prvl quote
Last: | $ |
---|---|
Change Percent: | -0.16% |
Open: | $19.09 |
Close: | $18.91 |
High: | $19.25 |
Low: | $18.35 |
Volume: | 103,841 |
Last Trade Date Time: | 02/12/2020 04:42:18 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $19.09 | $18.91 | $19.25 | $18.35 | 103,841 | 02-12-2020 |
$ | $18.62 | $18.94 | $19.1143 | $18.41 | 242,919 | 02-11-2020 |
$ | $18.45 | $18.49 | $18.64 | $18.40 | 132,297 | 02-10-2020 |
$ | $18.42 | $18.47 | $18.615 | $18.13 | 75,783 | 02-07-2020 |
$ | $18.54 | $18.45 | $18.70 | $17.68 | 199,690 | 02-06-2020 |
$ | $19.00 | $18.48 | $19.00 | $18.41 | 80,042 | 02-05-2020 |
$ | $18.65 | $18.98 | $19.20 | $18.38 | 103,312 | 02-04-2020 |
$ | $18.95 | $18.60 | $18.975 | $18.3631 | 54,332 | 02-03-2020 |
$ | $18.60 | $18.90 | $19.09 | $18.60 | 93,421 | 01-31-2020 |
$ | $18.46 | $18.56 | $18.75 | $18.10 | 56,594 | 01-30-2020 |
$ | $18.25 | $18.61 | $18.87 | $18.00 | 53,061 | 01-29-2020 |
$ | $18.31 | $18.22 | $18.77 | $17.71 | 50,566 | 01-28-2020 |
$ | $18.00 | $17.87 | $18.29 | $17.3759 | 86,404 | 01-27-2020 |
$ | $18.00 | $18.12 | $18.52 | $17.74 | 72,667 | 01-24-2020 |
$ | $18.49 | $18.09 | $18.60 | $17.60 | 137,813 | 01-23-2020 |
$ | $18.27 | $18.50 | $19.24 | $18.01 | 225,156 | 01-22-2020 |
$ | $18.41 | $18.29 | $18.85 | $17.99 | 125,486 | 01-21-2020 |
$ | $18.08 | $18.53 | $18.70 | $17.69 | 178,251 | 01-20-2020 |
$ | $18.08 | $18.53 | $18.70 | $17.69 | 178,251 | 01-17-2020 |
$ | $17.00 | $18.00 | $18.08 | $16.90 | 213,616 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Prevail Therapeutics Inc. Company Name:
PRVL Stock Symbol:
NYSE Market:
NEW YORK, NY / ACCESSWIRE / January 8, 2021 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Altimar Acquisition Corp. (NYSE: ATAC ) relat...
Shares of Eli Lilly (NYSE: LLY) jumped by 6% on Tuesday. The healthy gain came after the drugmaker raised its full-year 2020 revenue and earnings guidance, and provided a positive outlook for 2021. Lilly also announced plans to acquire Prevail Therapeutics (NASDAQ: PRVL) . ...
Eli Lilly (NYSE: LLY) will soon add a new asset to its portfolio. The veteran pharmaceutical company announced on Tuesday that it has signed a definitive agreement to acquire gene therapy specialist Prevail Therapeutics (NASDAQ: PRVL) . The price is $22.50 per share in c...